Search PubMed⌕ Search

Biomedical subjects

N Pearce

Publications and source records attributed to N Pearce.

At least 73 records · Page 4Linked to original sources

The New Zealand Socioeconomic Index: developing and validating an occupationally-derived indicator of socio-economic status.

OBJECTIVE: Following revision of the international standard classification (ISCO88), to update and validate on health data an occupationally derived indicator of socio-economic status (SES) adapted to changing occupational and demographic conditions. METHOD: The development of the New Zealand Socioeconomic Index (NZSEI) is based on a 'returns to human capital' model of the stratification process and uses data from the 1991 New Zealand Census (n = 1,051, 926) to generate scores for 97 occupational groups. The construct validation of the scale is carried out on data from the 1992-93 nationwide Household Health Survey (n = 3,000) using three health indicators (self-assessed health, cigarette smoking, general practitioner visits). RESULTS: In general, the results are consistent with expected socio-economic patterns drawn from the literature for the three indicators. CONCLUSIONS: While further work is required on a number of methodological and conceptual issues, the NZSEI provides a robust, standardised and internationally comparable occupational scale of SES for both males and females in either full- or part-time employment. IMPLICATIONS: The NZSEI can be used on routinely collected occupational data. It has a clear conceptual rationale, updates existing SES scales, and provides a link to international standards in SES and occupational classification.

Adult↗

Asthma prevalence and deprivation: a small area analysis.

STUDY OBJECTIVE: To investigate the relation between the prevalence of asthma symptoms in adults and deprivation in the area of residence. DESIGN: Two complementary surveys carried out between 1991-1993 yielding adult asthma symptom prevalence throughout New Zealand. Deprivation is measured by the NZDep91 index of deprivation for small areas. SETTING: New Zealand. PARTICIPANTS: A random sample of 25,042 adults aged 20-50 years. MAIN RESULTS: After controlling for possible confounding by age, gender, and ethnicity, the 12 month period prevalence rates of asthma in this representative sample of New Zealand adults are significantly higher in the three most deprived area categories than in the least deprived (tenth) category. The prevalence ratio for the most deprived category compared with the least deprived category is 1.29 with 95% confidence intervals (CI) 1.14, 1.47. There is a linear increase in asthma prevalence with increasing area deprivation (chi 2(1) = 32.20, p < 0.001). Independently, the rates are also 1.41 (95% CI 1.29, 1.54) times higher among Maori and 1.29 (95% CI 1.10, 1.52) times higher among the Pacific Island group than among the remaining, mostly European, respondents. CONCLUSIONS: The relation between asthma in adults and area deprivation is unlikely to be attributable to study biases or confounding. Further work should examine the possible role of modifiable deprivation factors in this relation.

Adolescent↗

Health expectancy in New Zealand, 1981-1991: social variations and trends in a period of rapid social and economic change.

STUDY OBJECTIVE: To assess social variations and trends in health expectancy over a period of rapid social and economic change. DESIGN: Cross sectional survey data on the association between social status--gender, socioeconomic class and ethnic group--and measures of health status at two points in time approximately a decade apart. The Sullivan method of calculating health expectancy was used. SETTING: The adult population of New Zealand in the periods 1980-81 and 1992-93. PARTICIPANTS: Representative samples of the adult civilian non-institutionalised population of 6,891 (1980-81) and 5,873 (1992-93) respectively. MAIN RESULTS: In comparison with life expectancy, adjusting for health status narrowed the gender gap but widened socioeconomic and ethnic differentials. These results were replicated for three measures--self reported health, mobility, and handicap--suggesting a robustness of outcome to specific indicators. Comparable data over the period of study were only available for the mobility measure. Increases in longevity appeared to be fully absorbed by minor disability. Ethnic and socioeconomic disadvantages remained static or widened for the 15-64 age group, suggesting a potential social polarisation in the disability transition. CONCLUSIONS: The operationalization of health expectancy appears to be rather robust to specific indicators. Health expectancy may provide a sensitive health impact assessment of social and economic policy. Existing theories of the disability transition may need to be modified to take account of social variation, at least in the special case of disability free health expectancy over the 15-64 age range.

Adolescent↗

Two year follow up of pulmonary function values among welders in New Zealand.

OBJECTIVES: To examine whether welding is a risk factor for an accelerated decline in pulmonary function. METHODS: 2 Year follow up of pulmonary function and respiratory symptoms among 54 welders and 38 non-welders in eight New Zealand welding sites. RESULTS: There were no significant differences in age, height, smoking habits, ethnicity, or total time in industrial work between welders and non-welders. No overall differences were noted in the changes of pulmonary function variables between the two study groups. However, when the comparison was restricted to smokers, welders had a significantly greater (p = 0.02) annual decline (88.8 ml) in FEV1 than non-welders, who had a slight non-significant annual increase (34.2 ml). Also, welders without respiratory protection or local exhaust ventilation while welding had a greater annual decline both in forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) than welders with protection (p = 0.001 and 0.04, respectively). Among welders a significant association was found between the acute across shift change and the annual decline in FEV1. Chronic bronchitis was more common among welders (24%) than non-welders (5%). Only one welder (2%) but eight non-welders (21%) reported having asthma. CONCLUSIONS: Welders who smoked and welders working without local exhaust ventilation or respiratory protection have an increased risk of accelerated decline in FEV1.

Adult↗

Relationship between fetal growth and the development of asthma and atopy in childhood.

BACKGROUND: A study was undertaken to investigate the relationship between birth anthropometric measures and the subsequent development of asthma, airway hyperresponsiveness, and atopy in later childhood. METHODS: A longitudinal study was performed on 734 subjects (71%) from a cohort of children born in Dunedin, New Zealand in 1972-73. The birth anthropometric measures were available from hospital records and the main outcome measures of reported asthma, skin prick tests, and methacholine hyperresponsiveness were measured at the age of 13 years, while the serum total IgE was measured at 11 years. RESULTS: After adjustment for other factors, infants with a larger head circumference at birth tended to have higher serum total IgE at 11 years of age (p = 0.02) but IgE was not associated significantly with birth length or birth weight. The adjusted odds ratio for raised serum IgE (>150 IU/ml) in infants with a head circumference of 37 cm or more was 3.4 (95% CI 1.4 to 7.9). In contrast, recent asthma symptoms were positively associated with birth length (p = 0. 04) but not with head circumference. The adjusted odds ratio for asthma in the previous two years in infants with a birth length of 56 cm or more was 6.4 (95% CI 2.0 to 19.8). Infants with a birth weight of less than 3.0 kg had an odds ratio for reported asthma of 0.2 (95% CI 0.0-0.6). There were no significant associations of any of the birth parameters with skin prick positivity, reported hay fever, or eczema. CONCLUSIONS: These results suggest that increased fetal growth is related to an increased risk of asthma and atopy in childhood. The precision of the findings is limited by the small numbers in the extreme categories of each birth parameter, but the results are consistent with intrauterine programming of the developing respiratory and immune systems.

Adolescent↗

Measuring morbidity in adult asthmatics.

SETTING: Whereas prevalence studies usually involve a general population sample, morbidity studies often involve the evaluation of factors that affect asthma severity within an asthmatic population. OBJECTIVE: To review methods of measuring morbidity in adult asthmatics, and to assess the appropriateness of the available methods in a variety of research contexts. FINDINGS: As in prevalence studies, symptoms are the cornerstone of studies of asthma morbidity. These may be supplemented by physiological measures including daily peak flow measurement, but bronchial hyper-responsiveness (BHR) testing is usually impractical, and there is no simple relationship between current asthma severity and current levels of BHR in individuals. Health service and medication usage are often taken as measures of asthma morbidity, but they may be inappropriate in studies in which increased contact with the health services is an intended or unintended effect of participation. Measures of quality of life can be a useful complement to more 'objective' methods. CONCLUSIONS: In studies of morbidity in adult asthmatics, the emphasis should be on using 'appropriate methodology', and methods that may be appropriate in one context may be completely inappropriate in another.

Adult↗

Epidemiological studies on genetic polymorphism: study design issues and measures of occurrence and association.

As with other epidemiological studies, the design and analysis of a study including genetic polymorphisms generally involve relating a particular disease or health outcome to a particular exposure or genetic trait, while assessing the presence of systematic error, controlling random error and assessing effect modification (interaction) with other exposures or traits. In studies of determinants and mechanisms of disease, markers of genetic polymorphism are generally treated either as exposure variables or as effect modifiers. In epidemiological studies the study base can be completely enumerated, and the cases can be identified as either incident or prevalent cases (incidence and prevalence studies). Alternatively, the study may involve cases of the disease (or condition) under investigation and a control group sampled from the study base that generated the cases (incidence and prevalence case-control studies). Most available studies on metabolic polymorphism and cancer risk are incidence case-control studies. Their major methodological problem is the selection of controls, which may be an important source of bias. Another important limitation of many available studies is the small sample size, which may be inadequate for assessing statistical interaction when the metabolic polymorphism is treated as an effect modifier.

Case-Control Studies↗

ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.

A series of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids have been synthesized and evaluated as inhibitors of the recombinant human form of ATP-citrate lyase. The best of these have Ki's in the 200-1000 nM range. As the corresponding thermodynamically favored gamma-lactone prodrugs, a number of compounds are able to inhibit cholesterol and fatty acid synthesis in HepG2 cells and reduce plasma triglyceride levels in vivo. The best of these, compound 77, is able to induce clear hypocholesterolemic and hypotriglyceridaemic responses when administered orally to rat and dog. These results provide evidence to support the hypothesis that compounds which inhibit ATP-citrate lyase have the potential to be a novel class of hypolipidemic agent, which possess combined hypocholesterolemic and hypotriglyceridemic activities.

ATP Citrate (pro-S)-Lyase↗

Classification of asthma severity: should the international guidelines be changed?

BACKGROUND: International guidelines recommend that, in addition to symptoms and medication requirements, measurements of forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) are necessary for the objective assessment of asthma severity. The guidelines suggest that parity exists between measurements of FEV1 and PEF when expressed as percentage of predicted normal values, and that asthma severity can be classified as mild, moderate or severe on the basis of FEV and PEF measurements of > 80%, 60-80% and < 60% of predicted values, respectively. OBJECTIVE: To determine the relationship between measurements of FEV1 and PEF when expressed as percentage predicted values. METHODS: A total of 1198 paired measurements of FEV1 and PEF were obtained from the medical records of a random sample of 25 adult asthmatic patients attending a hospital-based chest clinic. Measurements of lung function were expressed as a percentage of predicted normal values, using the European Respiratory Society prediction equations for PEF and FEV1. For the individual paired measurements, the mean differences between PEF and FEV percentage predicted were calculated. Measurements of lung function were used to determine asthma severity with <60%, 60-80%, and >80% predicted FEV1 and PEF values representing severe, moderate and mild asthma, respectively. The proportion of paired measurements in which differences in classification resulted from the use of FEV1 or PEF percentage predicted values was then calculated. RESULTS: In asthma of differing severity, there was considerable variability between measurements of FEV1 and PEF when expressed as percentage predicted values; calculation of the FEV1% predicted resulted in lower values than those of the PEF percentage predicted, with a mean difference of -17.2% (95% CI -16.3%, -18.1%). There was agreement in classification of asthma severity in only 49.9% (598/1198) of paired measurements. Different prediction equations, while variably altering the degree of misclassification, did not correct the basic differences in the assessment of asthma severity dependent on the use of FEV or PEF. CONCLUSION: FEV1 and PEF values, expressed as percentage predicted, are not equivalent. Pending further evaluation, the authors suggest that published asthma guidelines should avoid the assumption of parity between these two measurements.

Adolescent↗

Chronic bronchitis, work related respiratory symptoms, and pulmonary function in welders in New Zealand.

OBJECTIVES: A cross sectional study of respiratory symptoms and lung function in welders was performed at eight New Zealand welding sites: 62 current welders and 75 non-welders participated. METHODS: A questionnaire was administered to record demographic data, smoking habit, and current respiratory symptoms. Current and previous welding exposures were recorded to calculate a total lifetime welding fume exposure index. Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF) were measured before the start of the shift. RESULTS: There were no significant differences in ethnicity, smoking habits, or years of work experience between welders and non-welders. Symptoms of chronic bronchitis were more common in current welders (11.3%) than in non-welders (5.0%). Of those workers with a cumulative exposure index to welding fume > or = 10 years, 16.7% reported symptoms of chronic bronchitis compared with 4.7% of those with a cumulative exposure index < 4 years (odds ratio (OR) 4.1, 95% confidence interval (95% CI) 0.90 to 17.6). Workers with chronic bronchitis had significantly lower measures of baseline PEF (p = 0.008) and FEV/FVC ratio (p = 0.001) than workers without chronic bronchitis. Multivariate analysis showed that current smoking (OR 9.3, 1.0 to 86.9) and total exposure index to welding fumes > 10 years (OR 9.5, 1.3 to 71.9) were independent risk factors for chronic bronchitis. The report of any work related respiratory symptom was more prevalent in welders (30.7%) than non-welders (15.0%) and workers with these symptoms had significantly lower FEV, (p = 0.004) and FVC (p = 0.04) values. Multivariate analysis identified a high proportion of time spent welding in confined spaces as the main risk factor for reporting these symptoms (OR 2.8, 1.0 to 8.3). CONCLUSION: This study has documented a high prevalence of symptoms of chronic bronchitis and other work related respiratory symptoms in current welders. Also, workers with chronic bronchitis had reduced PEF and FEV/FVC compared with those without chronic bronchitis. These symptoms related both to cigarette smoking and a measure of lifetime exposure to welding fume.

Adolescent↗

Case-control study of salmeterol and near-fatal attacks of asthma.

BACKGROUND: A case-control study was undertaken to investigate the hypothesis that the use of the long acting beta agonist salmeterol increases the risk of a near-fatal attack of asthma. METHODS: The cases comprised admissions to the intensive care unit (ICU) for asthma in 14 major hospitals within the Wessex region in 1992. For each of the cases four age-matched controls were selected from asthma admissions to the same hospital during the same period. Information on prescribed drug therapy for the 48 cases and 185 controls was collected from the hospital admission records. RESULTS: The patients admitted to the ICU had greater chronic asthma severity and had generally been prescribed more asthma drugs than the control admissions to hospital. The relative risk of a near-fatal attack of asthma in patients prescribed inhaled salmeterol was 2.32 (95% CI 1.05 to 5.16), p = 0.04. However, the salmeterol relative risk decreased to 1.42 (95% CI 0.49 to 4.10), p = 0.52 when the analysis was restricted to the more chronically severe patients (those in the subgroup of patients with a hospital admission for asthma in the previous 12 months). These findings suggest that the increased unadjusted relative risk with salmeterol is predominantly due to confounding by severity--that is, the increased relative risk is due to patients with more severe asthma (at greatest risk of a near-fatal asthma attack) being preferentially prescribed salmeterol. This interpretation is supported by the finding in this study that, within the control group (selected from the population of asthmatics requiring hospital admission), salmeterol was preferentially prescribed to the most severe patients (a threefold greater prescription of salmeterol to control patients if they had been admitted to hospital in the 12 months prior to the index admission). There was no increased risk of a near-fatal attack of asthma in patients prescribed a beta agonist by metered dose inhaler (OR 0.75 (95% CI 0.31 to 1.78), p = 0.51). In contrast, the relative risks for beta agonists delivered by nebulisation (OR 3.86 (95% CI 1.99 to 7.50), p < 0.001) and oral theophylline (OR 2.45 (95% CI 1.26 to 4.78), p < 0.01) were increased and did not markedly decrease when the analysis was restricted to the more severe asthmatic subjects. CONCLUSIONS: Although these findings are not conclusive, particularly because of the small numbers involved in some subgroup analyses, they suggest that the use of salmeterol by patients with chronic severe asthma is not associated with a significantly increased risk of a near-fatal attack of asthma. If a near-fatal asthma attack is considered to be an intermediate step in a process by which a severe attack of asthma may become fatal, these results would suggest that salmeterol is unlikely to be associated with an increased risk of death, at least by this mechanism.

Adolescent↗